デフォルト表紙
市場調査レポート
商品コード
1301115

治療用ベッドの市場規模、シェア、動向分析レポート:製品別(臨床用ベッド、家庭用ベッド、付属品)、用途別(急性期治療ベッド、救命救急ベッド、長期ベッド)、最終用途別、地域別、セグメント予測、2023年~2030年

Therapeutic Bed Market Size, Share & Trends Analysis Report By Product (Clinical Beds, Household Beds, Accessories), By Application (Acute Care Beds, Critical Care Beds, Long-term Beds), By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 158 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
治療用ベッドの市場規模、シェア、動向分析レポート:製品別(臨床用ベッド、家庭用ベッド、付属品)、用途別(急性期治療ベッド、救命救急ベッド、長期ベッド)、最終用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年06月22日
発行: Grand View Research
ページ情報: 英文 158 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

治療用ベッド市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の治療用ベッド市場規模は2023年から2030年にかけてCAGR 5.09%で成長し、2030年には65億米ドルに達すると予測されています。

がん、心臓疾患、神経疾患、腎臓疾患などの慢性疾患の有病率の増加と老年人口の増加が市場の主な促進要因です。WHOによると、2020年には慢性疾患の有病率が57%増加し、近い将来の市場成長に拍車がかかると予想されています。2020年にCOVID-19が流行し、治療用ベッドの需要が大幅に増加しました。

パンデミックは、入院患者の増加により、救急用品、医薬品、人工呼吸器や病院用ベッドなどの医療機器の需要を押し上げました。さらに、企業はヘルスケア従事者を支援するため、提携や新製品の発売など、いくつかの戦略を採用しています。例えば、2020年8月、プロジェクトC.U.R.E.は、ストライカー社から22,500台の救急救命ベッド(ERB)セットを受け取っています。マットレス、点滴ポール、ベッドフレームがERBキットに含まれていました。その結果、この市場は近い将来大きく成長する可能性が高いです。

さらに、褥瘡は世界のヘルスケア・システムにとって一般的かつ重大な経済的課題であり、米国のヘルスケア・システムには毎年235億米ドル以上のコストがかかっています。さまざまなメーカーが、特殊ベッド、治療用マットレス、体位変換ソリューションなど、褥瘡の負担を軽減するためのソリューションを提供し始めました。さらに、COVID-19パンデミックの発生後、病院やリハビリテーション・センターで除圧ベッド&マットレスの需要が拡大しています。これらの要因が予測期間中の市場成長を後押しすると期待されます。

治療用ベッド市場レポートハイライト

  • 臨床用ベッド製品セグメントが2022年に約48.75%の最大シェアを占めました。
  • 事故件数の増加、高齢者人口の増加、生命を脅かす感染症の流行に起因するICU入院率の高さが、このセグメントを牽引しています。
  • 急性期病床の用途分野は2022年に約43.0%の最大シェアを占めました。
  • この成長は、陣痛管理(出産)、傷害の治療、精神疾患の重症度軽減、増悪や合併症からの保護などの多機能用途に起因しています。
  • 欧州市場は、外科手術数の増加、高齢者人口の増加、同地域の有利な償還政策により、2022年には35.7%の大幅な売上シェアを占めました。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • 製品
    • 応用
    • 最終用途
    • 地域の範囲
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • Gvrの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の形成と検証
  • モデル詳細
    • 商品フロー解析(モデル1)
    • 出来高価格分析(モデル2)
  • 二次情報のリスト
  • 一次情報のリスト
  • 略語のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合シナリオ

第3章 治療用ベッド市場:変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場促進要因分析
    • 長期にわたる介護を必要とする慢性疾患の増加
    • 在宅ヘルスケアの需要の高まり
    • 公立および私立の病院インフラの改善
    • 高齢者人口の増加
  • 市場抑制要因分析
    • 治療用ベッドの価格が高い
    • 利用可能な技術と資金が限られているため、新興国での先住民族の製造業が妨げられている
  • 市場機会分析
    • メーカーの技術進歩
    • 分娩用ベッド ISの発売の増加により、世界の治療用ベッド市場の成長が期待される
  • 普及と成長の見通しマッピング
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 新型コロナウイルス感染症(COVID-18)の影響と新型コロナウイルス感染症後の回復分析

第4章 治療用ベッド市場:製品セグメント分析、2018~2030年(100万米ドル)

  • 定義と範囲
  • 製品市場シェア分析、2022年および2030年
  • セグメントダッシュボード
    • 臨床用ベッド
    • 家庭用ベッド
    • 付属品

第5章 治療用ベッド市場:用途別セグメント分析、2018~2030年(100万米ドル)

  • 定義と範囲
  • 用途別市場シェア分析、2022年および2030年
  • セグメントダッシュボード
    • 急性期治療用ベッド
    • 救命救急ベッド
    • 長期ベッド

第6章 治療用ベッド市場:最終用途セグメント分析、2018~2030年(100万米ドル)

  • 定義と範囲
  • 最終用途市場シェア分析、2022年および2030年
  • セグメントダッシュボード
    • 病院とクリニック
    • 生殖ケアセンター
    • その他

第7章 治療用ベッド市場:地域市場分析、製品別、用途別、最終用途別、2018年~2030年(100万米ドル)

  • 治療用ベッド:市場シェア分析、2022年
  • 北米
    • 北米の治療用ベッド市場、2017~2030年(100万米ドル)
    • 米国
    • カナダ
  • 欧州
    • 欧州の治療用ベッド市場、2017~2030年(100万米ドル)
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋地域の治療用ベッド市場、2017~2030年(100万米ドル)
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの治療用ベッド市場、2017~2030年(100万米ドル)
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • MEA治療用ベッド市場、2017年~2030年(100万米ドル)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 企業プロファイル

  • 企業プロファイル
    • HILL-ROM SERVICES, INC.(BAXTER)
    • ARJOHUNTLEIGH(ARJO)
    • Invacare Corporation
    • STRYKER
    • MEDLINE INDUSTRIES, INC.
    • GF HEALTH PRODUCTS, INC.
    • HARD MANUFACTURING COMPANY INC
    • BAKARE BEDS LTD
    • AMICO CORPORATION
    • MEDICAL DEPOT.INC.(DRIVE DEVILBISS HEALTHCARE)
    • GENDRON, INC.
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America therapeutic beds market, by country, 2017 - 2030 (USD Million)
  • Table 4. North America therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 5. North America therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 6. North America therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 7. U.S therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 8. U.S. therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 9. U.S therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 10. Canada therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 11. Canada therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 12. Canada therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 13. Europe therapeutic beds market, by country, 2017 - 2030 (USD Million)
  • Table 14. Europe therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 15. Europe therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 16. Europe therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 17. UK therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 18. UK therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 19. UK therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 20. Germany therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 21. Germany therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 22. Germany therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 23. France therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 24. France therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 25. France therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 26. Italy therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 27. Italy therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 28. Italy therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 29. Spain therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 30. Spain therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 31. Spain therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 32. Denmark therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 33. Denmark therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 34. Denmark therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 35. Sweden therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 36. Sweden therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 37. Sweden therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 38. Norway therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 39. Norway therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 40. Norway therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 41. Asia Pacific therapeutic beds market, by country, 2017 - 2030 (USD Million)
  • Table 42. Asia Pacific therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 43. Asia Pacific therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 44. Asia Pacific therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 45. China therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 46. China therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 47. China therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 48. Japan therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 49. Japan therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 50. Japan therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 51. India therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 52. India therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 53. India therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 54. Australia therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 55. Australia therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 56. Australia therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 57. South Korea therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 58. South Korea therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 59. South Korea therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 60. Thailand therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 61. Thailand therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 62. Thailand therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 63. Latin America therapeutic beds market, by country, 2017 - 2030 (USD Million)
  • Table 64. Latin America therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 65. Latin America therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 66. Latin America therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 67. Brazil therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 68. Brazil therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 69. Brazil therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 70. Mexico therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 71. Mexico therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 72. Mexico therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 73. Argentina therapeutic beds market, by material, 2017 - 2030 (USD Million)
  • Table 74. Argentina therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 75. Argentina therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 76. MEA therapeutic beds market, by country, 2017 - 2030 (USD Million)
  • Table 77. MEA therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 78. MEA therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 79. MEA therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 80. South Africa therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 81. South Africa therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 82. South Africa therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 83. South Arabia therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 84. Saudi Arabia therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 85. Saudi Arabia therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 86. UAE therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 87. UAE therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 88. UAE therapeutic beds market, by end use, 2017 - 2030 (USD Million)
  • Table 89. Kuwait therapeutic beds market, by product type, 2017 - 2030 (USD Million)
  • Table 90. Kuwait therapeutic beds market, by application, 2017 - 2030 (USD Million)
  • Table 91. Kuwait therapeutic beds market, by end use, 2017 - 2030 (USD Million)

List of Figures

  • Fig. 1 Therapeutic bed market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market summary (2022)
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Age standardized hospital admission rate per 100,000 population, 2022
  • Fig. 12 Annual health spending growth for selected categories, 2019 and 2020
  • Fig. 13 Health expenditure as a percentage of GDP in 2022 (out-of-pocket and public)
  • Fig. 14 Rate of hospitalization for COVID-19 with age
  • Fig. 15 Percentage distribution of population aged 65 years and over, by region: 2015 and 2050
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Public expenditure on health in 2022 or nearest (as % of GDP)
  • Fig. 18 Market opportunities relevance analysis (Current & future impact)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 21 Total number of hospital beds per 1,000 person during COVID-19
  • Fig. 22 COVID-19 hospital and ICU occupancy on March 28, 2021, compared with December 26, 2020
  • Fig. 23 Total health spending in Canada during COVID-19
  • Fig. 24 Therapeutic bed market: Product movement analysis
  • Fig. 25 Therapeutic bed market product outlook: Key takeaways
  • Fig. 26 Clinical beds market, 2018 - 2030 (USD Million)
  • Fig. 27 Regular beds market, 2018 - 2030 (USD Million)
  • Fig. 28 ICU bed capacity (per 100,000) by population
  • Fig. 29 The occupancy rate of ICU inpatient adult beds in 2022 for all causes
  • Fig. 30 Estimated number of ICU beds in India
  • Fig. 31 ICU beds market, 2018 - 2030 (USD Million)
  • Fig. 32 Pediatric beds market, 2018 - 2030 (USD Million)
  • Fig. 33 Birthing beds market, 2018 - 2030 (USD Million)
  • Fig. 34 Bariatric beds market, 2018 - 2030 (USD Million)
  • Fig. 35 Low air loss beds market, 2018 - 2030 (USD Million)
  • Fig. 36 Others market, 2018 - 2030 (USD Million)
  • Fig. 37 Household beds market, 2018 - 2030 (USD Million)
  • Fig. 38 Accessories market, 2018 - 2030 (USD Million)
  • Fig. 39 Therapeutic bed market: Application movement analysis
  • Fig. 40 Therapeutic bed market application outlook: Key takeaways
  • Fig. 41 Total number of acute care hospital beds per 1,000 person during COVID-19
  • Fig. 42 Acute care beds market, 2018 - 2030 (USD Million)
  • Fig. 43 The underlying cause of the differences in the dominant cardiovascular disease subtypes in Asian
  • Fig. 44 Critical care beds market, 2018 - 2030 (USD Million)
  • Fig. 45 Distribution of spending on services by types of services
  • Fig. 46 Proportion of older adults receiving long-term care at home in OECD countries in 2018
  • Fig. 47 Long-term beds market, 2018 - 2030 (USD Million)
  • Fig. 48 Therapeutic bed market: End-use movement analysis
  • Fig. 49 Therapeutic bed market end-use outlook: Key takeaways
  • Fig. 50 Hospital & Clinics's & clinics market, 2018 - 2030 (USD Million)
  • Fig. 51 Reproductive care centers market, 2018 - 2030 (USD Million)
  • Fig. 52 Other market, 2018 - 2030 (USD Million)
  • Fig. 53 Regional outlook, 2022 & 2030
  • Fig. 54 Regional market place: Key takeaways
  • Fig. 55 Chronic disease statistics
  • Fig. 56 North America therapeutic bed market, 2018 - 2030 (USD million)
  • Fig. 57 Type of admission, 2022
  • Fig. 58 U.S. therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 59 Total health expenditure
  • Fig. 60 Canada therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 61 Percentage of hospital admissions in selected European Union countries
  • Fig. 62 Europe therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 63 UK. therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 64 Germany therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 65 France therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 66 Italy therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 67 Spain therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 68 Denmark therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 69 Sweden therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 70 Norway therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 71 Asia Pacific therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 72 Japan therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 73 China therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 74 India therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 75 Australia therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 76 Thailand therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 78 Latin America therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 79 Brazil therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 80 Mexico therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 81 Argentina therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 82 MEA therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 84 Saudi Arabia therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 85 UAE therapeutic bed market, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait therapeutic bed market, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-840-4

Therapeutic Bed Market Growth & Trends

The global therapeutic bed market size is expected to reach USD 6.5 billion by 2030, registering a CAGR of 5.09% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic disorders, such as cancer, heart disorders, neurological disorders, kidney disorders, and others, and the growing geriatric population are the key driving factors for the market. According to the WHO, in 2020, the chronic illness prevalence increased by 57%, which is anticipated to spur market growth in the near future. The COVID-19 outbreak in 2020 increased the demand for therapeutic beds significantly.

The pandemic has boosted the demand for emergency supplies, medicines, and medical equipment, such as ventilators, and hospital beds, as a result of increased hospital admissions. In addition, firms are also adopting several strategies, such as collaborations and new product launches, to help healthcare workers. For instance, in August 2020, Project C.U.R.E. received 22,500 Emergency Relief Bed (ERB) sets from Stryker. A mattress, IV pole, and bed frame were included in the ERB kits. As a result, the market is likely to grow substantially in the near future.

Furthermore, pressure injuries are a common and significant economic challenge for healthcare systems globally, costing the U.S. healthcare system more than USD 23.50 billion each year. Various manufacturers began offering solutions, such as special beds, therapeutic mattresses, and repositioning solutions, to reduce the burden of pressure injuries. Moreover, after the onset of the COVID-19 pandemic, there has been extensive demand for pressure relief beds & mattresses in hospitals and rehabilitation centers. These factors are expected to boost the market growth over the forecast period.

Therapeutic Bed Market Report Highlights

  • The clinical beds product segment held the largest share of around 48.75% in 2022.
  • High ICU admission rates owing to a rise in the number of accidents, growth in the geriatric population, and outbreaks of life-threatening infectious diseases are driving the segment.
  • The acute care beds application segment held the largest share of around 43.0% in 2022.
  • This growth was attributed to multifunctional applications, such as managing labor (maternity), providing treatment to the injury, reducing the severity of mental illness, and protecting against exacerbation or complications.
  • The market in Europe held a substantial revenue share of 35.7% in 2022 owing to a rise in the number of surgical procedures, high geriatric population, and favorable reimbursement policies in the region.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Application
    • 1.1.3 End-use
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Scenario

Chapter 3 Therapeutic Beds Market: Variables, Trends, & Scope

  • 3.1 Market Segmentation and Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing prevalence of chronic diseases requiring long-term care
    • 3.2.2 Growing demand for home healthcare
    • 3.2.3 Improvements in public and private hospital infrastructure
    • 3.2.4 Growing geriatric population
  • 3.3 Market Restraint Analysis
    • 3.3.1 High cost of therapeutic beds
    • 3.3.2 Limited availability of technology and funds preventing indigenous manufacturing in emerging economies
  • 3.4 Market Opportunities Analysis
    • 3.4.1 Technological advancements by manufacturers
    • 3.4.2 Increasing launch of delivery beds IS expected to drive growth of the global therapeutic bed market
  • 3.5 Penetration & Growth Prospect Mapping
  • 3.6 Porter's Five Forces Analysis
  • 3.7 PESTEL Analysis
  • 3.8 Impact of COVID-18 & Post-COVID Recovery Analysis

Chapter 4 Therapeutic Beds Market: Product Segment Analysis, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Product Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Therapeutic Beds Market, by Product, 2018 - 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 - 2030
    • 4.5.1 Clinical Beds
      • 4.5.1.1 Clinical beds market, 2018 - 2030 (USD Million)
      • 4.5.1.2 Regular beds market, 2018 - 2030 (USD Million)
      • 4.5.1.3 ICU beds market, 2018 - 2030 (USD Million)
      • 4.5.1.4 Pediatric beds market, 2018 - 2030 (USD Million)
      • 4.5.1.5 Birthing beds market, 2018 - 2030 (USD Million)
      • 4.5.1.6 Bariatric beds market, 2018 - 2030 (USD Million)
      • 4.5.1.7 Low air loss beds beds market, 2018 - 2030 (USD Million)
      • 4.5.1.8 Others market, 2018 - 2030 (USD Million)
    • 4.5.2 Household Beds
      • 4.5.2.1 Household Beds Market, 2018 - 2030 (Usd Million)
    • 4.5.3 Accessories
      • 4.5.3.1 Accessories market, 2018 - 2030 (USD Million)

Chapter 5 Therapeutic Beds Market: Application Segment Analysis, 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Application Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Therapeutic Beds Market, by Application, 2018 - 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 - 2030
    • 5.5.1 Acute Care Beds
      • 5.5.1.1 Acute Care Beds Market, 2018 - 2030 (Usd Million)
    • 5.5.2 Critical Care Beds
      • 5.5.2.1 Critical Care Beds Market, 2018 - 2030 (Usd Million)
    • 5.5.3 Long-Term Beds
      • 5.5.3.1 Long-term beds market, 2018 - 2030 (USD Million)

Chapter 6 Therapeutic Beds Market: End-use Segment Analysis, 2018 - 2030 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 End-use Market Share Analysis, 2022 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Therapeutic Beds Market, by End-use, 2018 - 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 - 2030
    • 6.5.1 Hospitals & Clinics
      • 6.5.1.1 Hospital & Clinics Market, 2018 - 2030 (Usd Million)
    • 6.5.2 Reproductive Care Centers
      • 6.5.2.1 Reproductive Care Centers Market, 2018 - 2030 (Usd Million)
    • 6.5.3 Others
      • 6.5.3.1 Others market, 2018 - 2030 (USD Million)

Chapter 7 Therapeutic Beds Market: Regional Market Analysis, By Product, By Application, By End-Use, 2018 - 2030 (USD Million)

  • 7.1 Therapeutic Beds: Market Share Analysis, 2022
  • 7.2 North America
    • 7.2.1 North America therapeutic beds market, 2017 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Regulatory Framework & Reimbursement Scenario
      • 7.2.2.3 Competitive Scenario
      • 7.2.2.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Regulatory Framework & Reimbursement Scenario
      • 7.2.3.3 Competitive Scenario
      • 7.2.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe therapeutic beds market, 2017 - 2030 (USD Million)
    • 7.3.2 UK
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Regulatory Framework & Reimbursement Scenario
      • 7.2.3.3 Competitive Scenario
      • 7.2.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Regulatory Framework & Reimbursement Scenario
      • 7.3.3.3 Competitive Scenario
      • 7.3.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Regulatory Framework & Reimbursement Scenario
      • 7.3.4.3 Competitive Scenario
      • 7.3.4.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Regulatory Framework & Reimbursement Scenario
      • 7.3.5.3 Competitive Scenario
      • 7.3.5.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Regulatory Framework & Reimbursement Scenario
      • 7.3.6.3 Competitive Scenario
      • 7.3.6.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.3.7 Denmark
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Regulatory Framework & Reimbursement Scenario
      • 7.3.7.3 Competitive Scenario
      • 7.3.7.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8 Sweden
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Regulatory Framework & Reimbursement Scenario
      • 7.3.8.3 Competitive Scenario
      • 7.3.8.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Key Country Dynamics
      • 7.3.9.2 Regulatory Framework & Reimbursement Scenario
      • 7.3.9.3 Competitive Scenario
      • 7.3.9.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific therapeutic beds market, 2017 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Regulatory Framework & Reimbursement Scenario
      • 7.4.2.3 Competitive Scenario
      • 7.4.2.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Regulatory Framework & Reimbursement Scenario
      • 7.4.3.3 Competitive Scenario
      • 7.4.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Regulatory Framework & Reimbursement Scenario
      • 7.4.4.3 Competitive Scenario
      • 7.4.4.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Key Country Dynamics
      • 7.4.5.2 Regulatory Framework & Reimbursement Scenario
      • 7.4.5.3 Competitive Scenario
      • 7.4.5.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 Key Country Dynamics
      • 7.4.6.2 Regulatory Framework & Reimbursement Scenario
      • 7.4.6.3 Competitive Scenario
      • 7.4.6.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Key Country Dynamics
      • 7.4.7.2 Regulatory Framework & Reimbursement Scenario
      • 7.4.7.3 Competitive Scenario
      • 7.4.7.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America therapeutic beds market, 2017 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Regulatory Framework & Reimbursement Scenario
      • 7.5.2.3 Competitive Scenario
      • 7.5.2.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Regulatory Framework & Reimbursement Scenario
      • 7.5.3.3 Competitive Scenario
      • 7.5.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Regulatory Framework & Reimbursement Scenario
      • 7.5.4.3 Competitive Scenario
      • 7.5.4.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA therapeutic beds market, 2017 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 Key Country Dynamics
      • 7.6.2.2 Regulatory Framework & Reimbursement Scenario
      • 7.6.2.3 Competitive Scenario
      • 7.6.2.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Key Country Dynamics
      • 7.6.3.2 Regulatory Framework & Reimbursement Scenario
      • 7.6.3.3 Competitive Scenario
      • 7.6.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 Key Country Dynamics
      • 7.6.4.2 Regulatory Framework & Reimbursement Scenario
      • 7.6.4.3 Competitive Scenario
      • 7.6.4.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
    • 7.6.5 Kuwait
      • 7.6.5.1 Key Country Dynamics
      • 7.6.5.2 Regulatory Framework & Reimbursement Scenario
      • 7.6.5.3 Competitive Scenario
      • 7.6.5.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Company Profiles
    • 8.1.1 HILL-ROM SERVICES, INC. (BAXTER)
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial performance
      • 8.1.1.3 Product benchmarking
    • 8.1.2 ARJOHUNTLEIGH (ARJO)
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Product benchmarking
    • 8.1.3 Invacare Corporation
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial performance
      • 8.1.3.3 Product benchmarking
    • 8.1.4 STRYKER
      • 8.1.4.1 Company overview
      • 8.1.4.2 Product benchmarking
    • 8.1.5 MEDLINE INDUSTRIES, INC.
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial performance
      • 8.1.5.3 Product benchmarking
    • 8.1.6 GF HEALTH PRODUCTS, INC.
      • 8.1.6.1 Company overview
      • 8.1.6.2 Product benchmarking
    • 8.1.7 HARD MANUFACTURING COMPANY INC
      • 8.1.7.1 Company overview
      • 8.1.7.2 Product benchmarking
    • 8.1.8 BAKARE BEDS LTD
      • 8.1.8.1 Company overview
      • 8.1.8.2 Product benchmarking
    • 8.1.9 AMICO CORPORATION
      • 8.1.9.1 Company overview
      • 8.1.9.2 Product benchmarking
    • 8.1.10 MEDICAL DEPOT.INC. (DRIVE DEVILBISS HEALTHCARE)
      • 8.1.10.1 Company overview
      • 8.1.10.2 Product benchmarking
    • 8.1.11 GENDRON, INC.
      • 8.1.11.1 Company overview
      • 8.1.11.2 Product benchmarking